Moreover, the biomarker panel did not include additional markers of neuronal degeneration (e.g., neurofilament light chain), muscle damage (e.g., creatine kinase), or specific nutritional deficiencies (e.g., homocysteine), which would have enriched the interpretation of muscle activation in ALS. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.